Meir Preis

Title: Meir Preis: Innovator in Cancer Research

Introduction

Meir Preis is a notable inventor based in Hanover, NH (US). He has made significant contributions to the field of cancer research, particularly in understanding the response to neoadjuvant therapy in pancreatic ductal adenocarcinoma. His work focuses on the role of microRNA in determining patient outcomes.

Latest Patents

Meir Preis holds a patent titled "Methods for determining response to neoadjuvant therapy and survival using MicroRNA-10b." This invention provides methods for assessing the response to neoadjuvant therapy and metastasis-free survival based on microRNA expression levels. The patent also includes the use of protein cancer cell markers in biological samples, utilizing techniques such as in situ hybridization and immunohistochemical assays.

Career Highlights

Meir Preis is affiliated with Dartmouth College, where he conducts his research. His work has garnered attention for its potential to improve treatment strategies for pancreatic cancer patients. He has a total of 1 patent to his name, reflecting his innovative approach to medical research.

Collaborations

Meir Preis has collaborated with esteemed colleagues, including Lorenzo F Sempere and Murray Korc. These partnerships have enhanced the depth and impact of his research in the field of oncology.

Conclusion

Meir Preis is a dedicated inventor whose work in cancer research is paving the way for advancements in treatment methodologies. His innovative patent highlights the importance of microRNA in clinical applications, showcasing his commitment to improving patient outcomes.